Search | JOV | ARVO Journals

Showing 1 – 20 of 109

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Retinal vascular resistance increases, then later decreases, as glaucoma progresses

Stuart Keith Gardiner; Brad Fortune; Steven L Mansberger; Grant Cull

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):394.

ARVO Annual Meeting Abstract June 2024

The Comb Artifact: Extravascular Motion Detected by OCT Angiography, a Novel Observation Related to Glaucoma

Arwa Arrashoud; Juan Reynaud; Michaela Dunn; Stuart Keith Gardiner; Grant Cull; Brad Fortune

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5924.

ARVO Annual Meeting Abstract June 2024

Ocular Hypertension Treatment Study: 20 yr quality of life (QoL) outcomes

Mae O Gordon; Feng Gao; Michael A Kass; Julia Huecker; Pradeep Y Ramulu; Stuart Keith Gardiner; Linda M Zangwill

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4622.

ARVO Annual Meeting Abstract June 2024

Assessment of neurovascular coupling (NVC) in nonhuman primate (NHP) experimental glaucoma (EG) using laser speckle flowgraphy (LSFG) and optical coherence tomography angiography (OCTA) with flicker stimulation

Grant Cull; Juan Reynaud; Trinity Holthausen; Dawn Jennings; Michaela Dunn; Stuart Keith Gardiner; Kazuhiro Kurokawa; Brad Fortune

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1222.

ARVO Annual Meeting Abstract June 2024

Systemic pulse waveform parameters associated with vascular stiffness can predict the rate of functional progression in glaucoma and glaucoma suspects

Hongli Yang; Grant Cull; Mingrui Yang; Steven L Mansberger; Brad Fortune; Stuart Keith Gardiner

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4789.

ARVO Annual Meeting Abstract June 2024

Optic Nerve Head (ONH) Spatial Transcriptomics in Non-Human Primate (NHP) Experimental Glaucoma (EG)

Galen Williams; Jinho Lee; Cheri Stowell; Juan Reynaud; Hongli Yang; Stuart Keith Gardiner; Nicholas Marsh-Armstrong; Claude F Burgoyne; Priya Chaudhary

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):635.

ARVO Annual Meeting Abstract October 2023

Relationship of optic nerve head blood flow and pulsatility to IOP and early-stage glaucomatous damage.

Grant Cull; Michaela Dunn; Dawn Jennings; Juan Reynaud; Howard Lockwood; Trinity Holthausen; Stuart Keith Gardiner; Brad Fortune

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4735.

ARVO Annual Meeting Abstract June 2023

Retinal vessel pulsatile characteristics can predict functional progression in glaucoma suspects

Stuart Keith Gardiner; Cindy Albert; Brad Fortune; Steven L Mansberger; Grant Cull

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3778.

ARVO Annual Meeting Abstract June 2023

Peri-Neural Canal Scleral Bowing and Choroidal Thickness in High Myopia

Hongli Yang; Ya Xing Wang; JInwook Jeoung; Seungwoo Hong; Stuart Keith Gardiner; Juan Reynaud; Brad Fortune; Michael J A Girard; Glen Sharpe; Marcelo Nicolela; Balwantray C Chauhan; Claude F Burgoyne

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4159.

ARVO Annual Meeting Abstract June 2023

Variability in Posterior Laminar Surface segmentation and colocalization does not affect the detection of significant increases in retrolaminar Myelin Onset Distance in Non-Human Primate Early Experimental Glaucoma

Priya Chaudhary; Howard Lockwood; Cheri Stowell; Juan Reynaud; Hongli Yang; Stuart Keith Gardiner; Galen Williams; Eric Bushong; Mark Ellisman; Nicholas Marsh-Armstrong; Claude Burgoyne

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1023.

ARVO Annual Meeting Abstract June 2023

Effect of location of glaucomatous functional loss on aspects of quality of life

Cindy Albert; Stuart Keith Gardiner; Steven L Mansberger

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5511.

ARVO Annual Meeting Abstract June 2023

Functional microvascular volume as a proportion of tissue volume is reduced in the RNFL but not the ONH rim at the onset of experimental glaucoma

Michaela Dunn; Juan Reynaud; Grant Cull; Dawn Jennings; Howard Lockwood; Trinity Holthausen; Stuart Keith Gardiner; Ian A Sigal; Claude F Burgoyne; Adriana Di Polo; Brad Fortune

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3779.

ARVO Annual Meeting Abstract June 2023

During progression of glaucomatous damage, the rate of functional microvascular tissue loss exceeds loss of non-vascular tissue within the retinal nerve fiber layer, but declines proportionally within the optic nerve head neuroretinal rim

Brad Fortune; Grant Cull; Michaela Dunn; Dawn Jennings; Howard Lockwood; Trinity Holthausen; Stuart Keith Gardiner; Ian A Sigal; Claude Burgoyne; Adriana Di Polo

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3784.

ARVO Annual Meeting Abstract June 2023

Recruitment in the 80VIP study

Katie McAnnis; Jack Rees; Stuart Keith Gardiner; Lisa John; Mae O Gordon; Rohit Varma; Elizabeth Eckstrom; Greg Flamme; Kristy Dieters

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4243.

ARVO Annual Meeting Abstract June 2022

Pharmacodynamic response of optic nerve head (ONH) tissue blood flow measured by laser speckle flowgraphy (LSFG) after administration of PER-001, an endothelin receptor antagonist

Grant Cull; Crystal Jadach; Juan Reynaud; Kristine Ly; Michaela Dunn; Dawn Jennings; Trinity Holthausen; Howard Lockwood; Stuart Keith Gardiner; Lin Wang; Jennifer Wilk; Brad Fortune

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4029 – A0414.

ARVO Annual Meeting Abstract June 2022

Pharmacodynamic response of optic nerve head (ONH) vasculature measured by OCT-angiography (OCTA) after administration of the endothelin receptor antagonist PER-001

Brad Fortune; Grant Cull; Crystal Jadach; Kristine Ly; Michaela Dunn; Dawn Jennings; Trinity Holthausen; Howard Lockwood; Stuart Keith Gardiner; Lin Wang; Jennifer Wilk; Juan Reynaud

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3496.

ARVO Annual Meeting Abstract June 2022

Patient Reported Outcome Measures while using a device to objectively measure eye drop adherence

Steven L Mansberger; Facundo G Sanchez; Jack Phillip Rees; Stuart Keith Gardiner; Viridian Klei; Julie Duvdevany; Max L Kobak; Robert M Kinast

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3493.

ARVO Annual Meeting Abstract June 2022

Decreased retrolaminar Myelin protein expression in Non-Human Primate (NHP) Early Experimental Glaucoma (EG) is accompanied by increased Iba1(+) cell counts and decreased GFAP signal intensity

Priya Chaudhary; Cheri Stowell; Juan Reynaud; Stuart Keith Gardiner; Galen Williams; Imee Williams; Nicholas Marsh-Armstrong; Claude F Burgoyne

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):933 – A0402.

ARVO Annual Meeting Abstract June 2022

Correlating longitudinal Optical Coherence Tomography (OCT) structural change to retrolaminar myelin-related protein alteration in non-human primate (NHP) early experimental glaucoma (EG)

Hongli Yang; Priya Chaudhary; Cheri Stowell; Juan Reynaud; Stuart Keith Gardiner; Galen Williams; Imee Williams; Nicholas Marsh-Armstrong; Claude F Burgoyne

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3095.

ARVO Annual Meeting Abstract June 2022

Using Moving instead of Static Stimuli to Extend the Dynamic Range of Perimetry

Stuart Keith Gardiner; Steven L Mansberger

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3100.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Retinal vascular resistance increases, then later decreases, as glaucoma progresses

The Comb Artifact: Extravascular Motion Detected by OCT Angiography, a Novel Observation Related to Glaucoma

Ocular Hypertension Treatment Study: 20 yr quality of life (QoL) outcomes

Assessment of neurovascular coupling (NVC) in nonhuman primate (NHP) experimental glaucoma (EG) using laser speckle flowgraphy (LSFG) and optical coherence tomography angiography (OCTA) with flicker stimulation

Systemic pulse waveform parameters associated with vascular stiffness can predict the rate of functional progression in glaucoma and glaucoma suspects

Optic Nerve Head (ONH) Spatial Transcriptomics in Non-Human Primate (NHP) Experimental Glaucoma (EG)

Relationship of optic nerve head blood flow and pulsatility to IOP and early-stage glaucomatous damage.

Retinal vessel pulsatile characteristics can predict functional progression in glaucoma suspects

Peri-Neural Canal Scleral Bowing and Choroidal Thickness in High Myopia

Variability in Posterior Laminar Surface segmentation and colocalization does not affect the detection of significant increases in retrolaminar Myelin Onset Distance in Non-Human Primate Early Experimental Glaucoma

Effect of location of glaucomatous functional loss on aspects of quality of life

Functional microvascular volume as a proportion of tissue volume is reduced in the RNFL but not the ONH rim at the onset of experimental glaucoma

During progression of glaucomatous damage, the rate of functional microvascular tissue loss exceeds loss of non-vascular tissue within the retinal nerve fiber layer, but declines proportionally within the optic nerve head neuroretinal rim

Recruitment in the 80VIP study

Pharmacodynamic response of optic nerve head (ONH) tissue blood flow measured by laser speckle flowgraphy (LSFG) after administration of PER-001, an endothelin receptor antagonist

Pharmacodynamic response of optic nerve head (ONH) vasculature measured by OCT-angiography (OCTA) after administration of the endothelin receptor antagonist PER-001

Patient Reported Outcome Measures while using a device to objectively measure eye drop adherence

Decreased retrolaminar Myelin protein expression in Non-Human Primate (NHP) Early Experimental Glaucoma (EG) is accompanied by increased Iba1(+) cell counts and decreased GFAP signal intensity

Correlating longitudinal Optical Coherence Tomography (OCT) structural change to retrolaminar myelin-related protein alteration in non-human primate (NHP) early experimental glaucoma (EG)

Using Moving instead of Static Stimuli to Extend the Dynamic Range of Perimetry

To View More...

You must be signed into an individual account to use this feature.